Soluble Fas modulates interferon responsiveness.
Tsai
S L
SL
D017209:Apoptosis / Q000187:drug effects / Q000276:immunology; D053222:Fas Ligand Protein; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008562:Membrane Glycoproteins / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D017211:Treatment Failure; D019014:fas Receptor / Q000502:physiology*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D016898:Interferon-alpha; D008562:Membrane Glycoproteins; D019014:fas Receptor